BRPI0619018A2 - compound or a pharmaceutically acceptable salt or solvate thereof, use of a compound, and, composition - Google Patents
compound or a pharmaceutically acceptable salt or solvate thereof, use of a compound, and, compositionInfo
- Publication number
- BRPI0619018A2 BRPI0619018A2 BRPI0619018A BRPI0619018A BRPI0619018A2 BR PI0619018 A2 BRPI0619018 A2 BR PI0619018A2 BR PI0619018 A BRPI0619018 A BR PI0619018A BR PI0619018 A BRPI0619018 A BR PI0619018A BR PI0619018 A2 BRPI0619018 A2 BR PI0619018A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- solvate
- composition
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74018305P | 2005-11-28 | 2005-11-28 | |
PCT/US2006/045328 WO2007062193A1 (en) | 2005-11-28 | 2006-11-22 | Heterocycle-substituted 3-alkyl azetidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0619018A2 true BRPI0619018A2 (en) | 2016-11-29 |
Family
ID=37779312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0619018A BRPI0619018A2 (en) | 2005-11-28 | 2006-11-22 | compound or a pharmaceutically acceptable salt or solvate thereof, use of a compound, and, composition |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1954692A1 (en) |
KR (1) | KR20080073721A (en) |
AR (1) | AR058199A1 (en) |
BR (1) | BRPI0619018A2 (en) |
CR (1) | CR10014A (en) |
DO (1) | DOP2006000261A (en) |
EC (1) | ECSP088477A (en) |
IL (1) | IL191586A0 (en) |
MA (1) | MA30086B1 (en) |
NO (1) | NO20082919L (en) |
PE (1) | PE20070647A1 (en) |
RU (1) | RU2008126248A (en) |
SV (1) | SV2009002917A (en) |
TW (1) | TW200804317A (en) |
WO (1) | WO2007062193A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7906652B2 (en) | 2005-11-28 | 2011-03-15 | Merck Sharp & Dohme Corp. | Heterocycle-substituted 3-alkyl azetidine derivatives |
EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
AU2008317482A1 (en) * | 2007-10-24 | 2009-04-30 | Merck Sharp & Dohme Corp. | Synthesis and crystalline forms of CB-1 antagonist/inverse agonist |
EP2611788B1 (en) | 2010-09-03 | 2017-04-12 | University of Florida Research Foundation, Incorporated | Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use |
EP2683704B1 (en) | 2011-03-08 | 2014-12-17 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
WO2012120054A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683699B1 (en) | 2011-03-08 | 2015-06-24 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120056A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2805810B1 (en) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | PHARMACEUTICAL COMPOSITIONS CONTAINING 3- AMINO-AZETIDINE DERIVATIVES, THE NEW DERIVATIVES AND THEIR PREPARATION |
FR2805817B1 (en) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND THEIR PREPARATION |
FR2805818B1 (en) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | AZETIDINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
JP3939744B2 (en) * | 2003-06-11 | 2007-07-04 | メルク エンド カムパニー インコーポレーテッド | Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
AU2006242219A1 (en) * | 2005-05-02 | 2006-11-09 | Merck & Co., Inc. | Combination of dipeptidyl peptidase-IV inhibitor and a cannabinoid CB1 receptor antagonist for the treatment of diabetes and obesity |
-
2006
- 2006-11-20 AR ARP060105076A patent/AR058199A1/en unknown
- 2006-11-22 WO PCT/US2006/045328 patent/WO2007062193A1/en active Application Filing
- 2006-11-22 RU RU2008126248/04A patent/RU2008126248A/en not_active Application Discontinuation
- 2006-11-22 KR KR1020087012880A patent/KR20080073721A/en not_active Application Discontinuation
- 2006-11-22 TW TW095143274A patent/TW200804317A/en unknown
- 2006-11-22 BR BRPI0619018A patent/BRPI0619018A2/en not_active IP Right Cessation
- 2006-11-22 EP EP06838347A patent/EP1954692A1/en not_active Withdrawn
- 2006-11-23 DO DO2006000261A patent/DOP2006000261A/en unknown
- 2006-11-23 PE PE2006001495A patent/PE20070647A1/en not_active Application Discontinuation
-
2008
- 2008-05-20 IL IL191586A patent/IL191586A0/en unknown
- 2008-05-22 CR CR10014A patent/CR10014A/en not_active Application Discontinuation
- 2008-05-27 EC EC2008008477A patent/ECSP088477A/en unknown
- 2008-05-28 SV SV2008002917A patent/SV2009002917A/en not_active Application Discontinuation
- 2008-06-25 MA MA31075A patent/MA30086B1/en unknown
- 2008-06-27 NO NO20082919A patent/NO20082919L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20082919L (en) | 2008-08-27 |
EP1954692A1 (en) | 2008-08-13 |
CR10014A (en) | 2008-07-29 |
ECSP088477A (en) | 2008-06-30 |
TW200804317A (en) | 2008-01-16 |
SV2009002917A (en) | 2009-02-19 |
MA30086B1 (en) | 2008-12-01 |
PE20070647A1 (en) | 2007-08-11 |
RU2008126248A (en) | 2010-01-10 |
WO2007062193A1 (en) | 2007-05-31 |
KR20080073721A (en) | 2008-08-11 |
AR058199A1 (en) | 2008-01-23 |
DOP2006000261A (en) | 2007-07-15 |
IL191586A0 (en) | 2008-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0607545A2 (en) | compound, use of a compound of formula I or a pharmaceutically acceptable salt thereof, and pharmaceutical composition | |
BRPI0516609A (en) | pharmaceutically acceptable compound or salt, hydrate, or stereoisomer thereof, pharmaceutical composition, and use of a compound | |
BRPI0609802A2 (en) | compound, pharmaceutical composition and use of a compound | |
BRPI0818193A2 (en) | compound, pharmaceutically acceptable salt of a compound, pharmaceutical composition, and use of a compound | |
BRPI0614205A2 (en) | compound, pharmaceutical composition and compound use | |
BRPI0618904A2 (en) | compound, pharmaceutical composition, and compound use | |
BRPI0614730A2 (en) | compound, pharmaceutical composition, and use of a compound | |
BRPI0822033A2 (en) | Compound or salt thereof, pharmaceutical composition, use of a compound or salt, and kit | |
BRPI0917540A2 (en) | compound, pharmaceutically acceptable salt, pharmaceutical composition, and use of a pharmacologically acceptable compound or salt | |
BRPI0611025A2 (en) | compound, use of a compound, and pharmaceutically acceptable composition | |
BRPI0619018A2 (en) | compound or a pharmaceutically acceptable salt or solvate thereof, use of a compound, and, composition | |
BRPI0716171A2 (en) | compound, pharmaceutical composition and use of a compound. | |
BRPI0717699A2 (en) | "COMPOSITION AND ITS PROCESSES FOR PREPARATION, USE OF A COMPOSITION, AND COMESTIC USE OF A COMPOSITION! | |
BRPI0720124A2 (en) | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE. | |
BRPI0810696A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND | |
BRPI0815709A2 (en) | composition, pharmaceutical composition, and use of a compound. | |
BRPI0508263B8 (en) | 1, 2, 3,4-tetrahydro-isoquinoline derivatives, pharmaceutical composition, and use of 1, 2, 3,4-tetrahydro-isoquinoline derivative | |
BRPI0614162A2 (en) | dermocosmetic and use of a compound | |
BRPI0810161A2 (en) | COMPOUND, PHARMACEUTICAL PREPARATION, PHARMACEUTICAL COMPOSITION, AND USE OF A COMPOUND | |
BRPI0720637A2 (en) | COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT, STEREOISOMIC, TAUTOMERIC OR POLYMORPHIC FORM OF THEREOF, METHODS FOR TREATING A HOST AND INFECTION, PHARMACEUTICAL COMPOSITION, AND, USE OF THE COMPOUND | |
ZA200609798B (en) | Aqueous fungicidal composition and use thereof for combating harmful micro organisms | |
BRPI0716327A2 (en) | Phenylpropionamide Compound and Use | |
BRPI0716698A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION AND USE OF A COMPOUND | |
BRPI0810019A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND | |
CR10725A (en) | PIRAZOLINE COMPOUNDS AND THEIR USE AND PHARMACEUTICAL COMPOSIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA. |
|
B11Z | Dismissal: petition dismissal - article 216, par 2 of industrial property law |
Free format text: REFERENTE A PETICAO NO 20080079731/RJ DE 27/05/2008. |
|
B11M | Decision cancelled [chapter 11.13 patent gazette] |
Free format text: O DESPACHO 11.6.1 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0. |
|
B06H | Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette] |
Free format text: O DESPACHO 6.7 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |